U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients - Toronto Sun
5/28/2022 12:00:00 AM2 years 11 months ago
by Deena Beasley, Reuters
by Deena Beasley, Reuters
Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some U.S. doctors are reconsidering the pills for lower-risk patients.
Author of the article: Dr. Cesira Nencioni, director of infectious diseases at Misericordia hospital, holds COVID-19 treatment pill Paxlovid, in Grosseto, Italy, Feb. 8, 2022.Photo by Jennifer Loren… [+5587 chars]
full article...